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The acknowledgement by Argenson et al. (1) about 
establishing appropriate inclusion criteria for TOPKAT is 
appreciated and shows substantial insight. The potential 
for selection bias (particularly, but not exclusively, with 
cohort and non-randomised data) is ever present when 
considering comparative efficacy between two types of knee 
replacement. Even sophisticated post hoc adjustments and 
analyses can only account for, but never entirely obviate, 
such a critical and initial selection bias. Thresholds of 
disease and individual choice characteristics for implant 
type, by both surgeons and patients, are highly varied in 
normal practice and equipoise is often difficult to achieve 
(hence the Expertise design employed for TOPKAT) (2). 
Thus, the slightest bias, in an area which clearly lacks 
high effect sizes and enormous differences, will influence 
interpretation, conclusions (and therefore recommended 
practice). Using a randomised design in a carefully selected 
large population (suitable for both TKR and PKR) was a 
deliberate and key feature of the study and addresses some 
of the issues from other high quality cohort work (3,4). 
The issue of complications and revision rate is one of 
the more notable aspects of the findings, and again, very 
sensibly raised by all commentary authors. Admittedly, an 
RCT of limited sample is not ideal to detect the incidence 
of low frequency events, but the differences between RCT 
findings and registry data cannot go unnoticed. The likely 
explanation is that, despite the pragmatic design and external 
validity of multiple sites in TOPKAT, and unlike the surgeon 
body in any larger cohort or registry, none of the surgeons 
in the RCT were new to PKR. As such, registries (which will 
also include the performance of technically inexperienced 
surgeons) will undoubtedly influence the revision rate of 
a technically demanding procedure. Add in a likely lower 
threshold for revision outside the controlled environment 
of an RCT, and the inconsistency becomes less surprising. 
The main consequence of this contention is the disquiet 
surrounding recommendations for best practice. Until 
improved methodology is found future policy setting for 
practice must take the findings from both types of study into 
account. TOPKAT presently tells us that PKR in the hands 
of experienced surgeons is somewhat better, whereas registry 
data estimates somewhat higher rates of revision (5), most 
likely contributed from a less PKR experienced surgeon 
group and amplified by heterogeneity of revision thresholds 
in routine practice (although some assumptions are made here 
as we do not have that granularity of data). The conclusion, 
as was stated in the paper and in the commentaries, is to 
recommend PKR, but with a surgeon comfortable and 
experienced in the procedure (6). Note TOPKAT did not 
show any real detriment to TKR in comparison, and therefore 
surgeons who perform a good TKR for anteromedial OA 
should not be dissuaded from doing so.
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We also cannot disagree with Mssrs Argenson, Jacquet, 
Ollivier over their thoughtful final conclusion sentence 
and their point about 10 year data. A point reinforced 
by Carlson and Sierra from the Mayo Clinic (7) in their 
equally considerate commentary referencing their own 
quality study comparing PKR (UKA) and TKR in the 
older patient (8). Five year data is useful but the 10-year 
picture will be more informative and we are in the process 
of collecting these longer term data. It will be less complete 
due to expected mortality but will still offer insight into 
the most appropriate long term surgical replacement for 
medial compartment OA. Indeed if there are larger or 
even different signals at 10 years we may have to revise our 
current interpretation. But that is exactly what constitutes 
good evaluation science – uncertainty, controlled bias, open 
mindedness and a justified conclusion.
However, as a postscript, merely obtaining 10-year data 
will never guarantee inclusion in any “best practice” policy 
creation. Bias can take many forms and many external 
factors can affect acceptance and implementation of even 
the most robust science. For example, TOPKAT, despite 
its Lancet credentials and being the largest ever, mid-term, 
level-1 randomised comparison of PKR v TKR was outright 
rejected for peer reviewed conference and publication on 
several occasions. The interpretation of such action is much 
less straightforward…!
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